CD86 and Sepsis: Interestingly, under continuing stimulation of LPS, a similar situation as sepsis condition, EgCF still has the ability to reduce M1 (F4/80+CD11b+CD86+) and boost M2 (F4/80+CD11b+CD206+) macrophages (Fig. 2d, e).